Advertisement

Journal of Neuro-Oncology

, Volume 70, Issue 3, pp 333–340 | Cite as

Immunohistochemical study for O6-methylguanine-DNA methyltransferase in the non-neoplastic and neoplastic components of gliomas

  • Satoshi Nakasu
  • Tadateru Fukami
  • Kazumi Baba
  • Masayuki Matsuda
Article

Abstract

Although the expression O6-methylguanine-DNA methyltransferase (MGMT) is an important hallmark for decision of nitrosourea chemotherapy for glioma patients, no immunohistochemical method for analysis of MGMT has been standardized yet. Gliomas usually contain non-neoplastic cells even deep in the tumor. It is not known which of these components expresses MGMT. To clarify this point, we investigated MGMT expression in the non-neoplastic cells in autopsy and surgical specimens by immuno-histochemistry. High grade gliomas were also studied to find a cut-off point for treatment decision. MGMT immunohistochemistry in the normal brain or brain with non-neoplastic disease revealed nuclear staining in some endothelial cells, inflammatory cells, ependymal cells, astrocytes and oligodendroglias. Some cells were double stained with CD68 (macrophages or microglias). The neurons were consistently MGMT-negative. High grade gliomas always contained an MGMT-positive non-neoplastic component. Although the endothelial cells were easily distinguished from the neoplastic cells, other cells were often mistaken for tumor cells. The population of MGMT-positive non-neoplastic cells was usually less than 10%. We set a cut off-point at 10% between the positive and negative groups because the statistical difference in the overall survival was most distinct at this value. In 51 high grade glioma patients, who received both radiotherapy and chemotherapy with nimustine (ACNU), the median overall survival of the MGMT-negative group (23months) was significantly longer than that of the MGMT-positive group (14months) (P<0.009). Multivariate analysis revealed that the negative MGMT expression was a significant prognostic variable next to the degree of surgical removal for the overall survival. In the MGMT-positive group, addition of platinum-based chemotherapy did not improve the survival.

Keywords

CD68 glioblastoma immunohistochemistry malignant glioma O6-methylguanine-DNA methyltransferase 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gerson, S 2002Clinical relevance of MGMT in the treatment of cancerJ Clin Oncol2023882399Google Scholar
  2. Nagane, M, Asai, A, Shibui, S, Nomura, K, Matsutani, M, Kuchino, Y 1992Expression of O6-methylguanine-DNA methyl-transferase and chloroethylnitrosourea resistance of human brain tumorsJpn J Clin Oncol22143149Google Scholar
  3. Anda, T, Shabani, HK, Tsunoda, K, Tokunaga, Y, Kaminogo, M, Shibata, S, Hayashi, T, Iseki, M 2003Relationship between expression of O6-methylguanine-DNA methyltransferase, glutathione-S-transferase pi in glioblastoma and the survival of the patients treated with nimustine hydrochloride: an immunohistochemical analysisNeurol Res25241248Google Scholar
  4. Belanich, M, Pastor, M, Randall, T, Guerra, D, Kibitel, J, Alas, L, Li, B, Citron, M, Wasserman, P, White, H, Eyre, H, Jaeckle, K, Schulman, S, Rector, D, Prados, M, Coons, S, Shapiro, W, Yarosh, D 1996Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustineCancer Res56783788Google Scholar
  5. Jaeckle, KA, Eyre, HJ, Townsend, JJ, Schulman, S, Knudson, HM, Belanich, M, Yarosh, DB, Bearman, SI, Giroux, DJ, Schold, SC 1998Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group studyJ Clin Oncol1633103315Google Scholar
  6. Mineura, K, Yanagisawa, T, Watanabe, K, Kowada, M, Yasui, N 1996Human brain tumor O(6)-methylguanine-DNA methyltransferase mRNA and its significance as an indicator of selective chloroethylnitrosourea chemotherapyInt J Cancer69420425Google Scholar
  7. Silber, JR, Blank, A, Bobola, MS, Ghatan, S, Kolstoe, DD, Berger, MS 1999O6-methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapyClin Cancer Res5807814Google Scholar
  8. Tanaka, S, Kobayashi, I, Oka, H, Fujii, K, Watanabe, T, Nagashima, T, Hori, T 2001Drug-resistance gene expression and progression of astrocytic tumorsBrain Tumor Pathol18131137Google Scholar
  9. Tanaka, S, Kobayashi, I, Utsuki, S, Oka, H, Fujii, K, Watanabe, T, Nagashima, T, Hori, T 2003O6-methylguanine-DNA methyltranspherase gene expression in gliomas by means of real-time quantitative RT-PCR and clinical response to nitrosoureasInt J Cancer1036772Google Scholar
  10. Komine, C, Watanabe, T, Katayama, Y, Yoshino, A, Yokoyama, T, Fukushima, T 2003Promoter hypermethylation of the DNA repair gene O6-methylguanine-DNA methyltransferase is an independent predictor of shortened progression free survival in patients with low-grade diffuse astrocytomaBrain Pathol13176184Google Scholar
  11. Lee, SM, Reid, H, Elder, RH, Thatcher, N, Margison, GP 1996Inter- and intracellular heterogeneity of O6-alkylguanine-DNA alkyltransferase expression in human brain tumors: possible significance in nitrosourea therapyCarcinogenesis17637641Google Scholar
  12. McLendon, RE, Cleveland, L, Pegram, C, Bigner, SH, Bigner, DD, Friedman, HS 1998Immunohistochemical detection of the DNA repair enzyme O6-methylguanine-DNA methyltransferase in formalin-fixed, paraffin-embedded astrocytomasLab Invest78643644Google Scholar
  13. Ohe, N, Saio, M, Kijima, M, Tamakawa, N, Suwa, T, Kojima, Y, Yano, H, Kaku, Y, Iwama, T, Shinoda, J, Sakai, N, Takami, T 2003In situ detection of O6-methylguanine-DNA methyltransferase messenger RNA in paraffin-embedded human astrocytic tumor tissue by nested in situ RT-PCR is useful in predicting chemotherapy-resistance of tumorsInt J Oncol22543549Google Scholar
  14. Friedman, HS, McLendon, RE, Kerby, T, Dugan, M, Bigner, SH, Henry, AJ, Ashley, DM, Krischer, J, Lovell, S, Rasheed, K, Marchev, F, Seman, AJ, Cokgor, I, Rich, J, Stewart, E, Colvin, OM, Provenzale, JM, Bigner, DD, Haglund, MM, Friedman, AH, Modrich, PL 1998DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant gliomaJ Clin Oncol1638513857Google Scholar
  15. Pegg, EA 2000Repair of O6-alkylguanine by alkyltransferasesMutation Res46283100Google Scholar
  16. Costello, JF, Futscher, BW, Tano, K, Graunke, DM, Pieper, RO 1994Graded methylation in the promoter and body of the O6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cellsJ Biol Chem2691722817237Google Scholar
  17. Esteller, M, Garcia-Foncillas, J, Andion, E, Goodman, SN, Hidalgo, OF, Vanaclocha, V, Baylin, SB, Herman, JG 2000Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agentsN Engl J Med34313501354Google Scholar
  18. Nakamura, M, Watanabe, T, Yonekawa, Y, Kleihues, P, Ohgaki, H 2001Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C → A:T mutations of the TP53 tumor suppressor geneCarcinogenesis2217151719Google Scholar
  19. Zhang, L, Lu, W, Miao, X, Xing, D, Tan, W, Lin, D 2003Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinomaCarcinogenesis2410391044Google Scholar
  20. Yin, D, Xie, D, Hofmann, W-K, Zhang, W, Asotra, K, Wong, R, Black, KL, Koeffler, HP 2003DNA repair gene O6-methlguanine-DNA methyltransferase: promoter hypermethylation associated with decreased expression and G:C to A:T mutations of p53 in brain tumorsMol Carcinog362331Google Scholar
  21. Nagane, M, Shibui, S, Oyama, H, Asai, A, Kuchino, Y, Nomura, K 1995Investigation of chemoresistance-related genes mRNA expression for selecting anticancer agents in successful adjuvant chemotherapy for a case of recurrent glioblastomaSurg Neurol44462468Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Satoshi Nakasu
    • 1
  • Tadateru Fukami
    • 1
  • Kazumi Baba
    • 1
  • Masayuki Matsuda
    • 1
  1. 1.Department of NeurosurgeryShiga University of Medical ScienceSeta, Ohtsu, Shiga-kenJapan

Personalised recommendations